European Researchers Launch Study of Gut Microbes, Cardiometabolic Diseases | GenomeWeb

NEW YORK (GenomeWeb News) – France's National Institute of Health and Medical Research (INSERM) is coordinating a European multi-partner project that will conduct metagenomics-based studies of gut microbes to understand the causes of and find ways to treat cardiometabolic diseases (CMDs), INSERM said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.